ChiCTR2100051782
尚未开始
/
/
/
2021-10-04
/
/
慢性肺疾病
REducing Delay through edUcation on eXacerbations for Chinese chronic lung disease patients
REducing Delay through edUcation on eXacerbations for Chinese chronic lung disease patients
2300 RC Leiden
The objectives of the study are to examine the effectiveness of REDUX in Chinese chronic lung disease patients. In addition, its preconditions (i.e., feasibility, appropriateness, and acceptability) will be evaluated in chronic lung disease patients and HCPs to assess whether REDUX will be successful in China.
连续入组
其它
不适用
N/A
国家自然科学基金委员会(72064038)；国家留学基金委(201807040051)
/
54;24
/
2022-10-31
2024-10-31
/
People who (a) are diagnosed with a chronic lung disease (chronic obstructive pulmonary disease or asthma, or chronic obstructive pulmonary disease overlapping with asthma), (b) are aged 20 years old or older, (c) have received treatment by the HCP in a PC setting in the past year, and (d) have had a minimum of two exacerbations in the past year.；
请登录查看Patients with mental disabilities, as diagnosed by the physician, or patients who cannot read will be excluded.；
请登录查看郑州大学
2300 RC Leiden
医药经济报2025-12-12
医学新视点2025-12-12
上海拓界生物医药2025-12-12
绽妍JUYOU2025-12-12
隆门资本2025-12-12
信邦制药2025-12-12
君实医学2025-12-12
触界生物2025-12-12
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
